
ICONS: ADOBE STOCK
SOURCE: VIVALNK
How important is 24-hour continuous vs. episodic data capture?
53% - Very important
38% - Somewhat important
7% - Not important 2% - Episodic data is enoughWhat is driving RPM adoption? (choose all that apply)
72% - Patients’ reluctance to visit doctors/hospitals
34% - Need new revenue streams
27% – Expansion outside geographical area
1% - Other
What applications will use RPM? (choose all that apply)
55% - COVID-19 monitoring
50% - Chronic conditions monitoring
41% - Preventing rehospitalization
39% - Acute conditions monitoring
38% - Cardiac monitoring
12% - Chemotherapy monitoring
9% - Other
What stage level is your RPM adoption?
21% - Already used/adopted
16% - Plans to adopt within 6 months
8% - Plans to adopt within 6 to 12 months
22% - Considering; no plans yet
34% - No plans to adopt
Where will RPM adoption be in 5 years?
43% - On-par with in-patient monitoring
35% - Surpass in-patient monitoring
18% - Less than in-patient monitoring
3% - Other
1% - Usage limited
Source: VivaLNK

Explore the June 2021 Issue
Check out more from this issue and find your next story to read.
Latest from Today's Medical Developments
- Beyond strength: How titanium enhances biocompatibility in surgical applications
- Machining with the pros: Kennametal experts share more than 90 years of combined experience
- Experts team up to take on milling challenge, achieve 40% faster machining time
- US manufacturing technology orders grow in March 2025
- Norman Noble boosts nitinol inventory for faster prototyping
- From honeybee brains and Egyptian mummies to customized human implants
- Star SU partners with REGO-FIX for cutting-edge machining solutions
- Maximize Efficiency with the WPG 7's Innovative Design